INSIGHTS ON DRUG DEVELOPMENT
-
How To Capture Growth In The Expanding Metabolic Drug Market
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
Streamline Drug Development With A Lab Informatics Platform
Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.
-
Excipients For Respiratory Delivery Of Biologics
With only 105 FDA-approved excipients for nasal and inhalation routes, formulating biologics for respiratory delivery demands precise excipient selection across both liquid and solid dosage forms.
-
Accelerating Phase: Supply Without Sacrificing Discipline
Faster clinical supply delivery starts with the right strategy. Explore how planning, collaboration, communication, and quality systems keep programs on track.
-
Reducing Cycle Time By 88% Through Strategic Solvent Replacement In Pharmaceutical Development10/14/2026
Replacing methylene chloride in a slow, labor-intensive API step led to a single-solvent, one-pot process with a shorter reaction time and improved yield and purity.
-
Maximizing Laboratory Efficiency With Automated Dual-Thermal Cycling3/26/2026
Accelerate tRNA lead discovery with automated digital PCR. Process 384 samples daily with minimal hands-on time, using dual thermal cyclers to scale from in vitro screening to clinical trials.
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow11/7/2025
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
Lonza Advanced Synthesis Capabilities Update September 2026: AI Drug Manufacturing9/28/2026
Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
-
Transforming Research Through Lab Automation7/6/2026
Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.
DRUG DEVELOPMENT SOLUTIONS
-
Routine cell culture? Check!
For researchers who need consistent experimental outcomes, Mateo TL enables all lab members to check and document cell growth status conveniently and comfortably.
Measure confluency consistently, thereby increasing the confidence in the success of their downstream experiments.
-
Characterize the Best-Fit Structure for Your NMR and MS Data
ACD/Structure Elucidator Suite is the industry-leading software solution for computer-assisted structure elucidation (CASE). It offers a reliable workflow and accurate results for de novo elucidation of complex organic compound structures.
Use Structure Elucidator Suite to:
- Determine structures using NMR and other analytical data
- Generate all the candidate structures that fit your NMR and MS data
- Rank the generated structures and identify the most probable one
- Determine 3D configuration from a 2D structure using NOESY/ROESY data
- Dereplicate previously identified compounds
- Search fragment databases or manually define fragments for partially known structures
- Report the final structure and add SDFiles to the prediction databases
-
Integrate an automated cell imaging system with high-resolution imaging and robust analytics into your processes to streamline workflows for fluorescence and brightfield assays.
-
Flow cytometry is a powerful and versatile technique to analyze the physical and chemical characteristics of cells or particles.
-
Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.